Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126823751 | 12682375 | 1 | I | 20160818 | 20160825 | 20160825 | EXP | CA-AMGEN-CANSP2016108931 | AMGEN | 0.00 | F | Y | 0.00000 | 20160824 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126823751 | 12682375 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
126823751 | 12682375 | 2 | C | PROLIA | DENOSUMAB | 1 | 0 | SOLUTION FOR INJECTION | |||||||||||
126823751 | 12682375 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
126823751 | 12682375 | 4 | SS | ACTONEL | RISEDRONATE SODIUM | 1 | Unknown | UNK | 0 | TABLET | |||||||||
126823751 | 12682375 | 5 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
126823751 | 12682375 | 6 | SS | CELEBREX | CELECOXIB | 1 | Unknown | UNK | 0 | CAPSULE | |||||||||
126823751 | 12682375 | 7 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | UNK | 0 | ||||||||||
126823751 | 12682375 | 8 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
126823751 | 12682375 | 9 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
126823751 | 12682375 | 10 | SS | SIMPONI | GOLIMUMAB | 1 | Unknown | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126823751 | 12682375 | 1 | Product used for unknown indication |
126823751 | 12682375 | 2 | Product used for unknown indication |
126823751 | 12682375 | 3 | Product used for unknown indication |
126823751 | 12682375 | 4 | Product used for unknown indication |
126823751 | 12682375 | 5 | Product used for unknown indication |
126823751 | 12682375 | 6 | Product used for unknown indication |
126823751 | 12682375 | 7 | Product used for unknown indication |
126823751 | 12682375 | 8 | Product used for unknown indication |
126823751 | 12682375 | 9 | Product used for unknown indication |
126823751 | 12682375 | 10 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126823751 | 12682375 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126823751 | 12682375 | Bedridden | |
126823751 | 12682375 | Drug ineffective | |
126823751 | 12682375 | Fracture | |
126823751 | 12682375 | Immobile | |
126823751 | 12682375 | Osteoporosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |